Bibliographic Details
| Title: |
Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study) |
| Authors: |
Versaci, Francesco francescoversaci@yahoo.it, Gaspardone, Achille, Tomai, Fabrizio, Ribichini, Flavio, Russo, Paolo, Proietti, Igino, Ghini, Anna Silvia, Ferrero, Valeria, Chiariello, Luigi, Agostino Gioffrè, Pier, Romeo, Francesco, Crea, Filippo, Gioffrè, Pier Agostino (AUTHOR), Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation Study (CORPORATE AUTHOR) |
| Source: |
Journal of the American College of Cardiology (JACC). Dec2002, Vol. 40 Issue 11, p1935-1942. 8p. |
| Subject Terms: |
*PREDNISONE, *IMMUNOSUPPRESSIVE agents, *CORONARY restenosis, *THROMBOLYTIC therapy |
| Abstract: |
: ObjectivesThis study tested the effect of oral prednisone on clinical and angiographic restenosis rate after successful stent implantation in patients with persistent elevation of systemic markers of inflammation after the procedure.: BackgroundExperimental studies have shown that corticosteroids have the potential to reduce the inflammatory response associated with stent implantation.: MethodsEighty-three patients undergoing successful stenting with C-reactive protein (CRP) levels >0.5 mg/dl 72 h after the procedure were randomized to receive oral prednisone or placebo for 45 days. The primary clinical end point was 12-month event-free survival rate (defined as freedom from death, from myocardial infarction, and from recurrence of symptoms requiring additional revascularization). The angiographic end points were restenosis rate and late loss at six months.: ResultsTwelve-month event-free survival rates were 93% and 65% in patients treated with prednisone and placebo, respectively (relative risk [RR] 0.18, 95% confidence intervals [CI], 0.05 to 0.61, p = 0.0063). Six-month restenosis rate and late loss were lower in prednisone-treated than in placebo-treated patients (7% vs. 33%, p = 0.001, and 0.39 ± 0.6 mm vs. 0.85 ± 0.6 mm, p = 0.001, respectively).: ConclusionsIn patients with persistently high CRP levels after successful coronary artery stent implantation, oral immunosuppressive therapy with prednisone results in a striking reduction of clinical events and angiographic restenosis rate. [Copyright &y& Elsevier] |
|
Copyright of Journal of the American College of Cardiology (JACC) is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
